Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the control of metabolic disorders. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://rajanmdme504901.canariblogs.com/trelaglutide-exploring-a-new-treatment-for-chronic-diseases-53783596